Yahoo! Finance Search - Finance Home - Yahoo! - Help

Thursday, August 25 2016 1:42pm ET - U.S. Markets close in 2 hours and 18 minutes.
Industry Center - Drug Manufacturers - Other
Industry Center > Drug Manufacturers - Other > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drug Manufacturers - Other News
Latest News
Thursday, Aug 25, 2016
·Teva Confirms PTAB’s Decisions on Two Patents in IPR Challenge to COPAXONE® 40 mg
Business Wire - Wed 5:46 pm ET
Wednesday, Aug 24, 2016
·Teva Stock Drops After Patent Invalidated
at TheStreet.com - Wed 3:49 pm ET
·RegeneRx Joint Venture to Begin Second Phase 3 Study Of RGN-259 for Dry Eye Syndrome in 3rd Quarter
PR Newswire - Wed 8:00 am ET
Tuesday, Aug 23, 2016
·Cumberland Pharmaceuticals Begins U.S. Shipments Of Ethyol® (amifostine) For Oncology Patient Support
PR Newswire - Tue 4:05 pm ET
Monday, Aug 22, 2016
·United Therapeutics Hurt By Competitive Pressure
- Mon Aug 22
Saturday, Aug 20, 2016
·Taro Announces Completion of $250 Million Share Repurchase Program
Business Wire - Fri Aug 19
Friday, Aug 19, 2016
·Sciclone Pharmaceuticals Inc (SCLN) President & CEO Friedhelm Blobel Sold $5 million of Stocks
- Thu Aug 18
Thursday, Aug 18, 2016
·Endo's President and CEO Adopts 10b5-1 Trading Plan
PR Newswire - Thu Aug 18
·Endo's President and CEO Adopts 10b5-1 Trading Plan
CNW Group - Thu Aug 18
·European Commission Grants Marketing Authorization for Teva’s CINQAERO® (reslizumab)
Business Wire - Thu Aug 18
Tuesday, Aug 16, 2016
·Cardiome Announces Recent Insider Purchases
PR Newswire - Tue Aug 16
·Cardiome Announces Recent Insider Purchases
CNW Group - Tue Aug 16
Monday, Aug 15, 2016
·Aeolus Announces Third Quarter Fiscal Year 2016 Financial Results
Marketwire - Mon Aug 15
·Emisphere Reports Second Quarter 2016 Financial Results
GlobeNewswire - Mon Aug 15
·Amarin Announces Underwriters’ Exercise of Option to Purchase Additional American Depositary Shares
GlobeNewswire - Mon Aug 15
·Apricus Biosciences Announces Completion of Transfer of the United Kingdom Marketing Authorization for Vitaros® to Ferring Pharmaceuticals
Thomson Reuters ONE - Mon Aug 15
·Apricus Biosciences Announces Completion of Transfer of the United Kingdom Marketing Authorization for Vitaros® to Ferring Pharmaceuticals
GlobeNewswire - Mon Aug 15
Friday, Aug 12, 2016
·Endo withdraws filing seeking abuse deterrent labeling for pain drug
at bizjournals.com - Fri Aug 12
·Endo (ENDP) Stock Climbs as Mizuho Upgrades to 'Buy'
at TheStreet.com - Fri Aug 12
·Endo International: Baby Valeant Gets an Upgrade
at Barrons.com - Fri Aug 12
More Latest News...
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Other Headlines
More Finance RSS Feeds


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2016, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?